| Literature DB >> 36017356 |
Jian Wang1, Jian Yang1, Guoxin Shi1, Weidong Li1, Yun Ju2, Liang Wei3, Jun Liu3,4, Ning Xu3,4.
Abstract
Corynebacterium glutamicum has been widely and effectively used for fermentative production of l-lysine on an industrial scale. However, high-level accumulation of end products inevitably leads to osmotic stress and hinders further increase of l-lysine production. At present, the underlying mechanism by which C. glutamicum cells adapt to high-lysine-induced osmotic stress is still unclear. In this study, we conducted a comparative transcriptomic analysis by RNA-seq to determine gene expression profiles under different high-lysine stress conditions. The results indicated that the increased expression of some metabolic pathways such as sulfur metabolism and specific amino acid biosynthesis might offer favorable benefits for high-lysine adaptation. Functional assays of 18 representative differentially expressed genes showed that the enhanced expression of multiple candidate genes, especially grpE chaperon, conferred high-lysine stress tolerance in C. glutamicum. Moreover, DNA repair component MutT and energy-transducing NADH dehydrogenase Ndh were also found to be important for protecting cells against high-lysine-induced osmotic stress. Taken together, these aforementioned findings provide broader views of transcriptome profiles and promising candidate targets of C. glutamicum for the adaptation of high-lysine stress during fermentation.Entities:
Keywords: C. glutamicum; DNA repair; high-lysine stress; molecular chaperon; osmoadaptation; transcriptome profiles
Year: 2022 PMID: 36017356 PMCID: PMC9395588 DOI: 10.3389/fbioe.2022.933325
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
Strains and plasmids used in this study.
| Plasmid or strain | Description | Source |
|---|---|---|
| Plasmids | ||
| pCRD206 | Temperature-sensitive replicon and |
|
| pXMJ19 |
| Lab stock |
| pECXK-99E |
| Lab stock |
| pXMJ19- | pXMJ19 derivative, containing the | This study |
| pXMJ19- | pXMJ19 derivative, containing the | This study |
| pXMJ19- | pXMJ19 derivative, containing the | This study |
| pXMJ19- | pXMJ19 derivative, containing the | This study |
| pXMJ19- | pXMJ19 derivative, containing the | This study |
| pXMJ19- | pXMJ19 derivative, containing the | This study |
| pXMJ19- | pXMJ19 derivative, containing the | This study |
| pXMJ19- | pXMJ19 derivative, containing the | This study |
| pXMJ19- | pXMJ19 derivative, containing the | This study |
| pXMJ19- | pXMJ19 derivative, containing the | This study |
| pXMJ19- | pXMJ19 derivative, containing the | This study |
| pXMJ19- | pXMJ19 derivative, containing the | This study |
| pXMJ19- | pXMJ19 derivative, containing the | This study |
| pXMJ19- | pXMJ19 derivative, containing the | This study |
| pXMJ19- | pXMJ19 derivative, containing the | This study |
| pXMJ19- | pXMJ19 derivative, containing the | This study |
| pXMJ19- | pXMJ19 derivative, containing the | This study |
| pXMJ19- | pXMJ19 derivative, containing the | This study |
| pECXK-99E- | pECXK-99E derivative, containing the | This study |
| pECXK-99E- | pECXK-99E derivative, containing the | This study |
| Strains | ||
| DH5α |
| Invitrogen |
| ATCC 13032 | Representative wild-type | Lab stock |
| |
| This study |
| |
| Lab stock |
| |
| This study |
| |
| This study |
| |
| Lab stock |
| |
| This study |
| |
| This study |
| |
| Lab stock |
| |
| This study |
| |
| This study |
| |
| This study |
| |
| Lab stock |
| |
| Lab stock |
| |
| This study |
| |
| Lab stock |
| |
| This study |
| |
| This study |
| |
| This study |
| |
| This study |
| |
| This study |
| |
| This study |
| |
| This study |
| |
| This study |
FIGURE 1Growth assay and RNA-seq analysis of C. glutamicum in response to lysine challenges. (A) Growth of C. glutamicum cells in CGXII minimum medium with different concentrations of l-lysine. Cells were inoculated into 100 ml flasks containing 20 ml of medium for 20 h at 32°C. (B) Growth curves and morphological features of C. glutamicum strain with and without l-lysine stress. The growth experiments were carried out in 250 ml flasks containing 100 ml of CGXII medium at 30°C. The arrows indicate time points for RNA harvest at the midexponential growth phase. Scanning electron microscopy (SEM) was used to examine the cell morphology of the WT, ST, and HL samples. (C) An overview of transcriptome analysis among different lysine-treated samples. Venn diagram and Volcano plots were used for visualization of differentially expressed genes (DEGs). “WT” represents non-lysine-treated samples, while “HL” indicates cells that suffered from a constant challenge of 160 g/L lysine. “ST” represents the midexponential samples subjected to 160 g/L lysine for 1 h.
FIGURE 2Scatter plot of enriched KEGG pathway analysis in ST (A) and HL (B) samples compared with the WT control. The x-axis represents the rich factor corresponding to each pathway, and the y-axis indicates the KEGG pathways. The dot denotes the number of DEGs, and the color reflects the range of a corrected p-value (padj). The top 20 most enriched KEGG pathways are shown.
FIGURE 3An overview of the major metabolic alterations affected by lysine treatment in C. glutamicum. Upregulated and downregulated genes are shown in red and blue, respectively. The color of the boxes represents the log2 (fold-change) for genes shown. The left square box represents the short-term lysine-treated ST samples, and the right square box represents the long-term lysine-treated HL samples. Note: glucose-6-P, glucose-6-phosphate; F-6-P, fructose 6-phosphate; F-1,6-BP, fructose 1,6-bisphosphate; DHAP, dihydroxyacetone phosphate; GA3P, glyceraldehyde 3-phosphate; 1,3-BPG, 1,3-bisphosphoglycerate; 3 PG, 3-phosphoglycerate; 2 PG, 2-phosphoglycerate; PEP, phosphoenolpyruvic acid; PYR, pyruvate; Ac-CoA, acetyl coenzyme A; 6-PGL, 6-phosphogluconolactone; 6-PG, 6-phosphogluconate; Ru5P, d-ribulose 5-phosphate; Xu5P, d-xylulose 5-phosphate; R5P, ribose 5-phosphate; S7P, sedoheptulose 7-phosphate; E4P, d-erythrose 4-phosphate; Cit, citrate; Iso, isocitrate; a-KG, alpha-ketoglutaric acid; Succ-CoA, succinyl coenzyme A; Succ, succinate; Fum, fumarate; Mal, l-malate; OAA, oxaloacetic acid; l-Asp, l-aspartate; Aspartyl-P, L-4-aspartyl phosphate; ASA, l-aspartate 4-semialdehyde; L-Hom, l-homoserine; DHDP, 2,3-dihydrodipicolinate; PDC, delta1-piperidine-2,6-dicarboxylate; DL-DAP, meso-diaminoheptanedioate; Met, l-methionine; SAM, S-adenosyl-l-methionine; APS, adenosine 5′-phosphosulfate; GTP, guanosine 5′-triphosphate; DHN-P3, 7,8-Dihydroneopterin 3′-triphosphate; DHN, 7,8-dihydroneopterin; HMDHP, 6-(hydroxymethyl)-7,8-dihydropterin; HMDHP-PP, 6-hydroxymethyl-7,8-dihydropterin diphosphate; DHP, dihydropteroate; THF, tetrahydrofolate; ADC, 4-amino-4-deoxychorismate; pABA, p-aminobenzoate; pgi, glucose-6-phosphate isomerase; pfkA, 6-phosphofructokinase; fda, fructose-bisphosphate aldolase; tpi, triosephosphate isomerase; gap, glyceraldehyde 3-phosphate dehydrogenase; pgk, phosphoglycerate kinase; gpmA, phosphoglyceromutase; eno, enolase; pck, phosphoenolpyruvate carboxykinase; ppc, phosphoenolpyruvate carboxylase; pyk, pyruvate kinase; serA, phosphoglycerate dehydrogenase; ioIT1/2, inositol transport protein; ptsG, beta-glucoside PTS system EIICBA component; ptsH, phosphocarrier protein HPr; ptsI, phosphoenolpyruvate-protein phosphotransferase; ppgk, polyphosphate glucokinase; glk, glucokinase; zwf, glucose-6-phosphate dehydrogenase; devB, 6-phosphogluconolactonase; gnd, 6-phosphogluconate dehydrogenase; rpe, ribulose-phosphate 3-epimerase; rpi, ribose 5-phosphate isomerase; tkt, transketolase; tal, transaldolase; ldh, l-lactate dehydrogenase; aceE, pyruvate dehydrogenase E1 component; gltA, citrate synthase; pta, phosphate acetyltransferase; prpC1, 2-methylcitrate synthase; acn, aconitate hydratase; icd, isocitrate dehydrogenase; odhA, 2-oxoglutarate dehydrogenase; sucDC, succinyl-coA synthetase; sdhCDAB, succinate dehydrogenase CDAB; fum, fumarate hydratase; mdh, malate dehydrogenase; mqo, malate dehydrogenase; aceA, isocitrate lyase; aceB, malate synthase; aspB, aspartate aminotransferase; lysC, aspartokinase; asd, aspartate-semialdehyde dehydrogenase; hom, homoserine dehydrogenase; thrB, homoserine kinase; metX, homoserine acetyltransferase; metB, cystathionine gamma-synthase; metY, O-acetylhomoserine (thiol)-lyase; metH, methionine synthase; metK, S-adenosylmethionine synthase; dapA, dihydrodipicolinate synthase; dapB, dihydrodipicolinate reductase; ddh, meso-diaminopimelate d-dehydrogenase; dapD, tetrahydrodipicolinate succinylase; lysA, diaminopimelate decarboxylase; lysE, lysine efflux permease; brnEF, branched-chain amino acid exporter; gdh, glutamate dehydrogenase; argJ, glutamate N-acetyltransferase; argB, acetylglutamate kinase; argC, N-acetyl-gamma-glutamyl-phosphate reductase; argD, acetylornithine aminotransferase; argF, ornithine carbamoyltransferase; argG, argininosuccinate synthase; argH, argininosuccinate lyase; cglK, K+ transport protein; mscS, mechanosensitive channel protein; mscL, mechanosensitive channel protein; proA, glutamate-5-semialdehyde dehydrogenase; proB, glutamate 5-kinase; proC, pyrroline-5-carboxylate reductase; betP, glycine betaine transporter; lcoP, ectoine betaine transporter; ectP, ectoine/proline/glycine betaine carrier EctP; proP, proline/betaine transporter; atpABCDFGH, ATP synthase subunits; folE, GTP cyclohydrolase 1; cg2700, alkaline phosphatase; folX, 7,8-dihydroneopterin aldolase; folK, 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine diphosphokinase; folP1, dihydropteroate synthase; folp2, dihydropteroate synthase; cg2581, glucosyl-3-phosphoglycerate phosphatase; pabAB, para-aminobenzoate synthetase; folC, dihydrofolate synthase; folA, dihydrofolate reductase; dps, starvation-induced DNA protecting protein; grpE/groES/groEL/dnaK/dnaJ, molecular chaperone; cysD, sulfate adenylyltransferase; cysH, phosphoadenosine phosphosulfate reductase; cysI, sulfite reductase; cysK, cysteine synthase; ssuD1, alkanesulfonate monooxygenase; cysN, sulfate adenylyltransferase; and ssuCBA, ABC-type aliphatic sulfonate transporter.
FIGURE 4Effects of some representative DEGs on conferring high-lysine tolerance. (A) A summary of 18 differentially expressed high-lysine-related genes. (B) Relative expression levels of 18 DEGs in selected samples based on RNA-seq data. (C) Cell growth of C. glutamicum recombinant strains containing the control plasmid pXMJ19 or its derivatives under stressful conditions with or without IPTG addition. Then, 160 g/L lysine was used to mimic osmotic stress that occurs during the fermentation process.
FIGURE 5Roles of DNA repair systems in protecting cells against high-lysine-induced osmotic stress. (A) Expression profiles of representative genes implicated in DNA repair mechanisms among ST and HL samples. (B) Growth assays of the wild-type and DNA repair-defective mutants with and without lysine treatment. After overnight pregrowth at 32°C, the cells were, respectively, shifted to CGXII medium with an initial OD600 of 0.1 and incubated for another 20 h with shaking. Then, 160 g/L lysine was used to mimic osmotic stress. (C) Growth assays of the wild-type, ∆mutT, and complemented strains in response to the challenge of 160 g/L lysine. The shuttle vector pECXK-99E was used for the expression of mutT gene in C. glutamicum.
FIGURE 6Role of the NADH dehydrogenase Ndh in protecting cells against high-lysine-induced osmotic stress. (A) Schematic diagram of Ndh in the oxidative phosphorylation pathway. (B,C) Growth assays of the wild-type, ∆ndh, and complemented strains without or with a high-lysine challenge.